HYDROGEN SULFATE SALT OF A BCL-2 INHIBITOR, RELATED CRYSTALLINE FORM,METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

It is provided a salt and related crystalline forms of Compound A: wherein the salt is the hydrogen sulfate salt, characterised by its X-ray powder diffraction diagram, method for preparing the same and pharmaceutical compositions containing it, and use of same for treatment of cancers. Il est décri...

Full description

Saved in:
Bibliographic Details
Main Authors LYNCH, MICHAEL, MASSON, LUDOVIC, VILLARD, FREDERIC, MOUCHET, PATRICK, TAULELLE, PASCAL
Format Patent
LanguageEnglish
French
Published 26.09.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:It is provided a salt and related crystalline forms of Compound A: wherein the salt is the hydrogen sulfate salt, characterised by its X-ray powder diffraction diagram, method for preparing the same and pharmaceutical compositions containing it, and use of same for treatment of cancers. Il est décrit un sel et des formes cristallines connexes du composé A : dans lesquelles le sel est le sel de sulfate d'hydrogène caractérisé par son diagramme de diffraction des rayons X sur poudre, une méthode de préparation et des compositions pharmaceutiques qui le contiennent, et une utilisation pour le traitement des cancers.
Bibliography:Application Number: CA20193117559